Sequences

Sample result

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

GLP-1, a diabetes hormone

Protein → Patent proteins · Automatic (Smith-Waterman)

Download as Excel

Every list and the search record, one sheet each.

Query
GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
Set
Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
5,000 sequences, 3,061 publications, 1,851 families

Charts

Identity against coverage

5,000 hits by identity and query coverage. 5,000 with a date.

Has a date707075758080858590909595100100Identity (%)Query coverage (%)
Show table
Hits by identity
BandHas a dateAll
100%553553
95 to 99.9%992992
90 to 94.9%2,6382,638
80 to 89.9%814814
70 to 79.9%33
Hits by query coverage
BandHas a dateAll
100%3,6063,606
95 to 99.9%876876
90 to 94.9%483483
80 to 89.9%3535

Hits by year

3,061 publications by year of first publication, 1990 to 2026.

Has a datePublications01002003001990199319961999200220052008201120142017202020232026
Show table
Publications by year of first publication
YearHas a dateAll
199022
199222
199311
199411
199511
199633
199722
199822
19991111
20001313
20012020
20023737
20033333
20043737
20055454
20066262
20077777
20088181
2009107107
2010101101
2011110110
2012121121
2013123123
2014135135
2015142142
2016144144
2017157157
2018149149
2019150150
2020156156
2021183183
2022161161
2023175175
2024181181
2025231231
20269696

Where hits align on the query

The top 20 hits on GLP-1, a query of 31 amino acids: 20 cover the whole query, none differs from it.

Aligned partDiffers from the queryGLP-1 · 31 amino acids151015202531HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGAAA55132.1A31422.1AAB11984.1DI506186DI527435AAB11995.1AAE02614.1DI540976DI521338DI502216DJ789879DI520483AAE49428.1AAE49430.1AAE49429.1AAE49432.1DI501808AAY78103.1BD613525BD613528
Show table
The top 20 hits on GLP-1, positions on the query
HitQuery fromQuery toIdentityDiffers atGaps atX at
AAA55132.1131100.0%NoneNoneNone
A31422.1131100.0%NoneNoneNone
AAB11984.1131100.0%NoneNoneNone
DI506186131100.0%NoneNoneNone
DI527435131100.0%NoneNoneNone
AAB11995.1131100.0%NoneNoneNone
AAE02614.1131100.0%NoneNoneNone
DI540976131100.0%NoneNoneNone
DI521338131100.0%NoneNoneNone
DI502216131100.0%NoneNoneNone
DJ789879131100.0%NoneNoneNone
DI520483131100.0%NoneNoneNone
AAE49428.1131100.0%NoneNoneNone
AAE49430.1131100.0%NoneNoneNone
AAE49429.1131100.0%NoneNoneNone
AAE49432.1131100.0%NoneNoneNone
DI501808131100.0%NoneNoneNone
AAY78103.1131100.0%NoneNoneNone
BD613525131100.0%NoneNoneNone
BD613528131100.0%NoneNoneNone

Patents 3.1K

Columns
Tick the columns each row shows, then choose Show. The arrows move a column.

3,061 publications from 692 applicants, 83 with no applicant, match these filters.

Conjuchem, Inc. 23 publications, continued

  1. US 6514500-A2003-02-04

    Long lasting synthetic glucagon like peptide {GLP-!}

    Conjuchem, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  2. US 6593295-A2003-07-15

    Long lasting insulinotropic peptides

    Conjuchem, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  3. JP 2003527312-A2003-09-16

    LONG LASTING INSULINOTROPIC PEPTIDES

    ConjuChem Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  4. US 6821949-A2004-11-23

    Long lasting synthetic glucagon-like peptide (GLP-1)

    ConjuChem, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  5. US 6849714-A2005-02-01

    Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components

    ConjuChem, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  6. US 6887470-A2005-05-03

    Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components

    Conjuchem, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  7. US 6887849-A2005-05-03

    Long lasting synthetic glucagon-like peptide {GLP-1}

    ConjuChem, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  8. JP 2005239736-A2005-09-08

    Modified Secretin and Method of Synthesizing Thereof

    Conjuchem Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  9. JP 2005255689-A2005-09-22

    LONG LASTING EXENDIN-4

    ConjuChem Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  10. JP 2005263807-A2005-09-29

    Modified Peptides YY and Conjugates Thereof

    Conjuchem Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  11. EP 1591453-A12005-11-02

    No title on record

    ConjuChem Inc. (CA)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  12. EP 1598365-A12005-11-23

    No title on record

    ConjuChem Inc. (CA)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  13. JP 2006151986-A2006-06-15

    LONG LASTING EXENDIN-4

    ConjuChem Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  14. US 8039432-B22011-10-18

    Method of treatment of diabetes and/or obesity with reduced nausea side effect

    Conjuchem, LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  15. US 8080516-B22011-12-20

    Long lasting synthetic exendin-4 peptide conjugates

    Conjuchem, LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  16. US 8084414-B22011-12-27

    Methods involving long lasting synthetic exendin-4-peptide conjugates

    Conjuchem, LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  17. US 8093206-B22012-01-10

    Methods involving long lasting synthetic exendin-4 peptide conjugates

    Conjuchem, LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  18. WO 0117568-A22001-03-15

    Pulmonary delivery for bioconjugation

    Conjuchem, Inc. (CA)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  19. JP 2003508501-A2003-03-04

    PULMONARY DELIVERY FOR BIOCONJUGATION

    CONJUCHEM INC

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  20. US 6706892-A2004-03-16

    Pulmonary delivery for bioconjugation

    Conjuchem, Inc.

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

Zealand Pharmaceuticals A/S (DK) 4 publications

  1. WO 0104156-A12001-01-18

    Peptides that lower blood glucose levels

    Zealand Pharmaceuticals A/S (DK)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  2. JP 2007001987-A2007-01-11

    PEPTIDES THAT LOWER BLOOD GLUCOSE LEVELS

    ZEALAND PHARMACEUTICALS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  3. JP 2002509082-A2002-03-26

    Pharmacologically active peptide complex with reduced tendency against enzymatic hydrolysis

    ZEALAND PHARMACEUTICALS AS

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  4. EP 1076066-A12001-02-14

    Peptides for lowering blood glucose levels

    Zealand Pharmaceuticals A/S (DK)

    Query Match 93.8%Identity 96.7%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             | ||||||||||||||||||||||||||||
    Hit    1 HGEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    29 of 30 identical, no gaps.

Bayer Corporation 2 publications

  1. WO 0123420-A22001-04-05

    Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use

    Bayer Corporation (US)

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

  2. US 7507714-A2009-03-24

    Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use

    Bayer Corporation

    Query Match 96.3%Identity 100.0%

    Best alignment

    Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
             ||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
    

    30 of 30 identical, no gaps.

TRANSKARYOTIC THERAPIES INC 2 publications

  1. WO 0136643-A12001-05-25

    Nucleic acid construct for optimized production of products

    TRANSKARYOTIC THERAPIES, INC. (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  2. JP 2003514532-A2003-04-22

    Nucleic acid construct for optimized production of products

    TRANSKARYOTIC THERAPIES INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

Scios Inc 4 publications

  1. JP 2001158749-A2001-06-12

    Sustained release of peptide

    SCIOS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  2. JP 2004099621-A2004-04-02

    Prolonged Delivery of Peptides

    Scios Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  3. US 6828303-A2004-12-07

    Prolonged delivery of peptides

    Scios, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  4. JP 2006213727-A2006-08-17

    Prolonged Delivery of Peptides

    SCIOS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

Eli Lilly and Company 205 publications

  1. WO 0155213-A22001-08-02

    Process for solubilizing glucagon-like peptide 1 compounds

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  2. WO 0198331-A22001-12-27

    Glucagon-like peptide-1 analogs

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  3. JP 2002507188-A2002-03-05

    Use of glucagon-like peptide-1 (GLP-1) or analogs to abolish catabolic changes after surgery

    ELI LILLY & CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  4. JP 2002508332-A2002-03-19

    Glucagon-like peptide-1 crystals

    ELI LILLY AND CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  5. WO 0246227-A22002-06-13

    Glp-1 fusion proteins

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  6. WO 0247715-A22002-06-20

    Compositions of peptide crystals

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  7. WO 0248183-A22002-06-20

    Compositions of peptide crystals

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  8. WO 0248192-A22002-06-20

    Amidated glucagon-like peptide-1

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  9. JP 2002526454-A2002-08-20

    Use of GLP-1 or analogs in treatment of stroke

    ELI LILLY AND CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  10. US 6555521-A2003-04-29

    Glucagon-like peptide-1 crystals

    Eli Lilly and Company

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  11. EP 1306092-A22003-05-02

    Use of glp-1 and analogs administered peripherally, in regulation of obesity

    Eli Lilly & Company (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  12. US 6583111-A2003-06-24

    Use of GLP-1 analogs and derivative adminstered peripherally in regulation of obesity

    Eli Lilly and Company

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  13. JP 2003523366-A2003-08-05

    Process for Solubilizing Glucagon-Like Peptide 1 Compounds

    Eli Lilly and Company

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  14. JP 2004501162-A2004-01-15

    GLUCAGON-LIKE PEPTIDE-1 ANALOGS

    Eli Lilly and Company

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  15. EP 1396499-A22004-03-10

    Process for solubilizing glucagon-like peptide 1 (GLP-1) compounds

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  16. US 6747006-A2004-06-08

    Use of GLP-1 or analogs in treatment of myocardial infarction

    Eli Lilly and Company

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  17. Glp-1 analog fusion plroteins

    Eli Lilly and Company (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  18. EP 1566180-A22005-08-24

    No title on record

    Eli Lilly & Company (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.